Diabetes has been identified as one of the major risk factors for developing severe forms of coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (1). While data show a higher incidence of severe acute respiratory distress syndrome and increased mortality in patients with diabetes, the majority of these patients have type 2 diabetes (2), and less is known about the implications of type 1 diabetes in COVID-19. A report from the U.K. describes the COVID-19 mortality rate as significantly higher in older patients with type 1 diabetes compared with those with type 2 diabetes (3). Among young adults with type 1 diabetes in the U.S., diabetic ketoacidosis (DKA) was commonly encountered in those diagnosed with COVID-19 (4). Little is known about adults with type 1 diabetes and COVID-19 who require hospitalization. The goal of this study was to define the clinical characteristics, outpatient diabetes management and control, and disease course of people with type 1 diabetes who were admitted to a tertiary care center for COVID-19.
We retrospectively reviewed the charts and collected data for all patients with an established diagnosis of …
[1]
K. Khunti,et al.
Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study
,
2020,
The Lancet Diabetes & Endocrinology.
[2]
Nudrat Noor,et al.
Type 1 Diabetes and COVID-19: Preliminary Findings From a Multicenter Surveillance Study in the U.S.
,
2020,
Diabetes Care.
[3]
M. Zervos,et al.
Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit
,
2020,
JAMA network open.
[4]
S. Hadjadj,et al.
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study
,
2020,
Diabetologia.
[5]
K. Khunti,et al.
Type 1 and Type 2 Diabetes and COVID-19 Related Mortality in England: A Whole Population Study
,
2020
.
[6]
Fang Lei,et al.
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
,
2020,
Cell Metabolism.